3 Reasons to Sell DBD and 1 Stock to Buy Instead

DBD Cover Image

What a fantastic six months it’s been for Diebold Nixdorf. Shares of the company have skyrocketed 49.4%, setting a new 52-week high of $85.45. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is there a buying opportunity in Diebold Nixdorf, or does it present a risk to your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free.

Why Do We Think Diebold Nixdorf Will Underperform?

We’re happy investors have made money, but we're swiping left on Diebold Nixdorf for now. Here are three reasons there are better opportunities than DBD and a stock we'd rather own.

1. Long-Term Revenue Growth Flatter Than a Pancake

Reviewing a company’s long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Unfortunately, Diebold Nixdorf struggled to consistently increase demand as its $3.81 billion of sales for the trailing 12 months was close to its revenue five years ago. This was below our standards and is a sign of poor business quality.

Diebold Nixdorf Quarterly Revenue

2. Cash Burn Ignites Concerns

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

While Diebold Nixdorf posted positive free cash flow this quarter, the broader story hasn’t been so clean. Diebold Nixdorf’s demanding reinvestments have drained its resources over the last five years, putting it in a pinch and limiting its ability to return capital to investors. Its free cash flow margin averaged negative 1.4%, meaning it lit $1.44 of cash on fire for every $100 in revenue.

Diebold Nixdorf Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

We like to invest in businesses with high returns, but the trend in a company’s ROIC is what often surprises the market and moves the stock price. Over the last few years, Diebold Nixdorf’s ROIC has unfortunately decreased significantly. We like what management has done in the past, but its declining returns are perhaps a symptom of fewer profitable growth opportunities.

Diebold Nixdorf Trailing 12-Month Return On Invested Capital

Final Judgment

Diebold Nixdorf doesn’t pass our quality test. After the recent surge, the stock trades at 15.4× forward P/E (or $85.45 per share). This valuation tells us a lot of optimism is priced in - we think there are better opportunities elsewhere. We’d recommend looking at one of our top software and edge computing picks.

Stocks We Would Buy Instead of Diebold Nixdorf

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.89
+0.00 (0.00%)
AAPL  259.20
+0.00 (0.00%)
AMD  246.83
+0.00 (0.00%)
BAC  53.35
+0.00 (0.00%)
GOOG  319.21
+0.00 (0.00%)
META  634.53
+0.00 (0.00%)
MSFT  384.37
+0.00 (0.00%)
NVDA  189.31
+0.00 (0.00%)
ORCL  155.62
+0.00 (0.00%)
TSLA  352.42
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.